Events & Presentations
Presentations
| Date | Title | Documents |
|---|---|---|
RedHill Biopharma Corporate Presentation |
|
Featured Events
| Date | Event Details | Remind Me |
|---|---|---|
|
Apr 7 - 9, 2019
|
H.C. Wainwright Global Life Sciences Conference
Guy Goldberg
, Chief Business Officer
JW Marriott Grosvenor House, London, UK
RedHill's presentation: Date: Tuesday, April 9, 2019 Time: 11:30 a.m. GMT Room: Spencer suite |
|
|
Mar 17 - 19, 2019
|
31st Annual ROTH Conference
Adi
Frish
Senior VP Business Development and Licensing
Ritz-Carlton, Laguna Niguel, Dana Point, CA
|
|
|
Dec 3, 2018
8:30 AM EST |
TALICIA Confirmatory Phase III Top-Line Results Webcast
|
|
|
Oct 22, 2018
|
United European Gastroenterology Week (UEG Week 2018)
Vienna, Austria
An abstract discussing the study’s top-line results, ‘A Phase III Randomized, Double Blind, Placebo-Controlled, Multicenter, Parallel Group Study To Assess The Efficacy And Safety Of Add-On Fixed-Dose Anti-Mycobacterial Therapy (RHB-104) In Moderately To Severely Active Crohn's Disease (MAP US)’ was presented as a late-breaking abstract today at the United European Gastroenterology Week (UEG Week 2018) by Dr. David Y. Graham, M.D., Professor of Medicine, Molecular Virology and Microbiology at Baylor College of Medicine, Houston and Lead Investigator of the MAP US study. |
|
|
Jul 30, 2018
|
Webcast – RHB-104 positive Phase III top-line results for Crohn’s disease
|
|
|
Dec 29, 2015
|
Prof. Thomas Borody Interview on Crohn's Disease and Gut Health
|
Upcoming Events & Presentations
| Date | Event Details | Remind Me |
|---|---|---|
|
Jun 3 - 6, 2019
|
BIO International Convention
Adi Frish
, Senior VP Business Development and Licensing
Pennsylvania Convention Center, Philadelphia, PA
|